Suzanne van Meer
Overview
Explore the profile of Suzanne van Meer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Veer R, van Hooff M, Werner E, Beuers U, Drenth J, Cuperus F, et al.
JHEP Rep
. 2024 Aug;
6(8):101132.
PMID: 39113899
Background & Aims: Although primary biliary cholangitis (PBC) is considered a rare disorder, accurate determination of its incidence and prevalence remains challenging due to limited comprehensive population-based registries. We aimed...
2.
Broekhoven A, Fiocco M, Sprengers D, Takkenberg R, van Meer S, van Erpecum K, et al.
Eur J Intern Med
. 2021 Dec;
97:56-61.
PMID: 34952770
Patients with Barcelona Clinic Liver Cancer intermediate stage hepatocellular carcinoma (HCC) theoretically are an excellent group to consider downstaging using locoregional therapy (LRT) since they do not have extrahepatic spread...
3.
Reinders M, van Meer S, Burgmans M, de Jong K, Klumpen H, de Man R, et al.
Eur J Cancer
. 2020 Aug;
137:214-223.
PMID: 32799035
Objective: Evaluation of the trends in incidence, diagnostics, treatment and survival of patients with hepatocellular carcinoma (HCC) in the Netherlands. Method: Data regarding incidence, diagnostics, primary treatment and survival of...
4.
Weusten B, Barret M, Bredenoord A, Familiari P, Gonzalez J, van Hooft J, et al.
Endoscopy
. 2020 Jun;
52(7):C7.
PMID: 32580233
No abstract available.
5.
Weusten B, Barret M, Bredenoord A, Familiari P, Gonzalez J, van Hooft J, et al.
Endoscopy
. 2020 Jun;
52(6):C6.
PMID: 32559813
No abstract available.
6.
Weusten B, Barret M, Bredenoord A, Familiari P, Gonzalez J, van Hooft J, et al.
Endoscopy
. 2020 May;
52(7):600-614.
PMID: 32462649
ESGE suggests flexible endoscopic treatment over open surgical treatment as first-line therapy for patients with a symptomatic Zenker's diverticulum of any size.Weak recommendation, low quality of evidence, level of agreement...
7.
Weusten B, Barret M, Bredenoord A, Familiari P, Gonzalez J, van Hooft J, et al.
Endoscopy
. 2020 May;
52(6):498-515.
PMID: 32375192
ESGE recommends the use of a graded pneumatic dilation protocol in achalasia, starting with a 30-mm dilation and followed by a 35-mm dilation at a planned interval of 2 - ...
8.
van Meer S, van Erpecum K, Sprengers D, Klumpen H, Jansen P, IJzermans J, et al.
Eur J Gastroenterol Hepatol
. 2016 May;
28(8):955-62.
PMID: 27196679
Objective: The risk of hepatocellular carcinoma (HCC) is increased in patients with metabolic syndrome (MS), possibly related to nonalcoholic fatty liver disease (NAFLD). As histological features of NAFLD may regress...
9.
Coenen S, van Meer S, Vrolijk J, Richter C, van Erpecum K, Mostert M, et al.
Liver Int
. 2016 Mar;
36(10):1425-32.
PMID: 27001619
Background & Aims: In low-endemic countries it is debated whether first-generation migrants should be screened for chronic hepatitis B infection. We describe the clinical impact of five large-scale Dutch screening...
10.
van Vlerken L, Lieveld F, van Meer S, Koek G, van Nieuwkerk K, Friederich P, et al.
Clin Res Hepatol Gastroenterol
. 2016 Feb;
40(5):622-630.
PMID: 26867863
Background And Objective: Adherence is essential in antiviral therapy for chronic hepatitis C. We investigated the effect of real-time medication monitoring on adherence to ribavirin. Methods: In this randomized controlled...